… morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal …

K Kumagai, I Rouvelas, JA Tsai… - Journal of British …, 2014 - academic.oup.com
… when chemotherapy alone was given, although this did not reach statistical significance
and a strict subgroup analysis based on the two main types of oesophageal cancer was not …

[HTML][HTML] Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level …

T Janowitz, P Thuss-Patience, A Marshall… - British journal of …, 2016 - nature.com
Background: Second-line chemotherapy treatment of patients with relapsed gastric and
oesophageal cancers in comparison with supportive care (SC) alone has been supported by …

[HTML][HTML] A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal …

F Klevebro, GA von Döbeln, N Wang, G Johnsen… - Annals of …, 2016 - Elsevier
… Neoadjuvant therapy—both chemotherapy alone (nCT) and combined chemoradiotherapy
(… ) in the oesophagus or gastro-oesophageal junction (GOJ) compared with surgery alone [1, 2…

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma …

YY Janjigian, K Shitara, M Moehler, M Garrido… - The Lancet, 2021 - thelancet.com
… gastric or gastro-oesophagealgastro-oesophageal junction, and oesophageal
adenocarcinoma. We report the first results for nivolumab plus chemotherapy versus chemotherapy

… in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a …

YJ Bang, E Van Cutsem, A Feyereislova, HC Chung… - The Lancet, 2010 - thelancet.com
… to study treatment (trastuzumab plus chemotherapy, n=298; chemotherapy alone, n=296), of
whom … plus chemotherapy group and 17·1 months (9–25) in the chemotherapy alone group. …

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

D Cunningham, WH Allum, SP Stenning… - … England Journal of …, 2006 - Mass Medical Soc
… In summary, our results show that perioperative chemotherapy with a regimen of ECF … ,
lower esophagus, or gastroesophageal junction, as compared with surgery alone. This treatment …

Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction

M Hulshof, HWM van Laarhoven - … & Research Clinical Gastroenterology, 2016 - Elsevier
… that the HR of the chemotherapy effect was larger in GOJ tumours compared to stomach or
… on perioperative CT versus surgery alone for resectable gastro-oesophageal cancer, the …

[HTML][HTML] Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

K Shitara, JA Ajani, M Moehler, M Garrido, C Gallardo… - Nature, 2022 - nature.com
… with advanced gastro-oesophageal cancer 12 . Here … chemotherapy versus chemotherapy
alone and the first results comparing nivolumab plus ipilimumab versus chemotherapy alone

Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer—do we need another randomised trial?

M Hingorani, T Crosby, A Maraveyas, S Dixit… - Clinical Oncology, 2011 - Elsevier
… = 9) and chemotherapy (n = 8) compared with surgery alone and … In comparison, five studies
of neoadjuvant chemotherapy … to 16 weeks of chemotherapy alone (cisplatin and leucovorin-…

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal …

EC Smyth, G Vlachogiannis, S Hedayat, A Harbery… - Gut, 2021 - gut.bmj.com
… -amplified metastatic gastro-oesophageal cancer patients2 and chemotherapy regimens …
associated with inferior outcomes compared with chemotherapy alone,8 42 we focused our …